BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10376172)

  • 1. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
    Cheng TO
    Clin Cardiol; 1999 Jun; 22(6):A27. PubMed ID: 10376172
    [No Abstract]   [Full Text] [Related]  

  • 2. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
    Mehta JL
    Clin Cardiol; 1998 Dec; 21(12):879-84. PubMed ID: 9853178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How hot is inflammation in acute coronary syndrome?
    Verheugt FW
    Eur Heart J; 2000 Dec; 21(24):1990-2. PubMed ID: 11102246
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
    Am J Cardiol; 2005 Oct; 96(8):1095-9. PubMed ID: 16214444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin in the prevention of cardiovascular disease in women.
    Schwartz DJ
    N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aspirin and inflammatory markers in patients with coronary disease].
    Iturbe T; Recaséns Mdel V; Moreno JA; Romero MS
    Med Clin (Barc); 2003 Apr; 120(12):476; author reply 476. PubMed ID: 12689557
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular events and COX-2 inhibitors.
    McGeer PL; McGeer EG; Yasojima K
    JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735747
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in response to aspirin: do we understand the clinical relevance?
    Campbell CL; Steinhubl SR
    J Thromb Haemost; 2005 Apr; 3(4):665-9. PubMed ID: 15703034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Diabetes; 2005 Aug; 54(8):2430-5. PubMed ID: 16046311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin beyond platelet inhibition.
    Verheugt FW; Gersh BJ
    Am J Cardiol; 2002 Jul; 90(1):39-41. PubMed ID: 12088777
    [No Abstract]   [Full Text] [Related]  

  • 12. What are all the things that aspirin does?
    Flower R
    BMJ; 2003 Sep; 327(7415):572-3. PubMed ID: 12969898
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation, atherosclerosis, and coronary artery disease.
    Kriszbacher I; Koppán M; Bódis J
    N Engl J Med; 2005 Jul; 353(4):429-30; author reply 429-30. PubMed ID: 16050062
    [No Abstract]   [Full Text] [Related]  

  • 14. Can aspirin be replaced in the treatment of coronary artery disease?
    Steely D; Talley JD
    J Ark Med Soc; 1997 Oct; 94(5):224-5. PubMed ID: 9343972
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of inflammation in acute coronary syndromes: review of the literature.
    Elhajj II; Haydar AA; Hujairi NM; Goldsmith DJ
    J Med Liban; 2004; 52(2):96-102. PubMed ID: 15884689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good news about gut-friendly aspirin.
    Harv Health Lett; 2003 Aug; 28(10):7. PubMed ID: 12936880
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ASA therapy or not?].
    Strandberg T; Vanhanen H
    Duodecim; 2002; 118(6):557-9. PubMed ID: 12232998
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin continues to attract research and debate, 115 years after its synthesis.
    Patrono C
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):251-4. PubMed ID: 24775613
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin for diabetic retinopathy.
    Kohner EM
    BMJ; 2003 Nov; 327(7423):1060-1. PubMed ID: 14604902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.